High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion

HFNC seems to increase droplet spread, so caution should be taken if it is applied for COVID-19, and adequate protective measures should be provided. Further research on viral spread and risks associated with HFNC therapy in COVID-19 patients is needed. https://bit.ly/3gQjjrY

Detalles Bibliográficos
Autores principales: Elshof, Judith, Hebbink, Rutger H.J., Duiverman, Marieke L., Hagmeijer, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453729/
https://www.ncbi.nlm.nih.gov/pubmed/32859674
http://dx.doi.org/10.1183/13993003.03004-2020
_version_ 1783575405840564224
author Elshof, Judith
Hebbink, Rutger H.J.
Duiverman, Marieke L.
Hagmeijer, Rob
author_facet Elshof, Judith
Hebbink, Rutger H.J.
Duiverman, Marieke L.
Hagmeijer, Rob
author_sort Elshof, Judith
collection PubMed
description HFNC seems to increase droplet spread, so caution should be taken if it is applied for COVID-19, and adequate protective measures should be provided. Further research on viral spread and risks associated with HFNC therapy in COVID-19 patients is needed. https://bit.ly/3gQjjrY
format Online
Article
Text
id pubmed-7453729
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-74537292020-09-02 High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion Elshof, Judith Hebbink, Rutger H.J. Duiverman, Marieke L. Hagmeijer, Rob Eur Respir J Agora HFNC seems to increase droplet spread, so caution should be taken if it is applied for COVID-19, and adequate protective measures should be provided. Further research on viral spread and risks associated with HFNC therapy in COVID-19 patients is needed. https://bit.ly/3gQjjrY European Respiratory Society 2020-10-08 /pmc/articles/PMC7453729/ /pubmed/32859674 http://dx.doi.org/10.1183/13993003.03004-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Elshof, Judith
Hebbink, Rutger H.J.
Duiverman, Marieke L.
Hagmeijer, Rob
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title_full High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title_fullStr High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title_full_unstemmed High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title_short High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
title_sort high-flow nasal cannula for covid-19 patients: risk of bio-aerosol dispersion
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453729/
https://www.ncbi.nlm.nih.gov/pubmed/32859674
http://dx.doi.org/10.1183/13993003.03004-2020
work_keys_str_mv AT elshofjudith highflownasalcannulaforcovid19patientsriskofbioaerosoldispersion
AT hebbinkrutgerhj highflownasalcannulaforcovid19patientsriskofbioaerosoldispersion
AT duivermanmariekel highflownasalcannulaforcovid19patientsriskofbioaerosoldispersion
AT hagmeijerrob highflownasalcannulaforcovid19patientsriskofbioaerosoldispersion

Ejemplares similares